A new study from MUSC Hollings Cancer Center researchers shows, for the first time, that a receptor called PPAR δ, or ...

Researchers have uncovered a new pathway that enables cancer cells to grow unchecked by disabling the immune system.

Table 1 Selected PPAR-targeted drugs in Phase II or III trials * Full size table Many research groups have “been fishing with the wrong bait” in trying to develop effective and safe anti ...

Fibrates are widely prescribed agonists of transcription factor peroxisome proliferator-activated receptor (PPAR)-α, and are used to treat patients with atherogenic dyslipidemia. These drugs ...

A new study from MUSC Hollings Cancer Center researchers shows, for the first time, that a receptor called PPAR δ, or ...

Tempest Therapeutics (NASDAQ:TPST) shares dropped Thursday after the company updated data from an ongoing trial designed to test its PPAR⍺ antagonist, amezalpat (TPST-1120), as a first-line ...